In re Biomet M2a Magnum Hip Implant Prods. Liab. Litig.
This text of 357 F. Supp. 3d 1389 (In re Biomet M2a Magnum Hip Implant Prods. Liab. Litig.) is published on Counsel Stack Legal Research, covering United States Judicial Panel on Multidistrict Litigation primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.
Opinion
Before the Panel: Defendants in three actions move under Panel Rule 10.2 to vacate our order that conditionally remanded the actions listed on Schedule A to their respective transferor districts. Defendants request that, instead of sending these cases to their originating courts, we instead send the actions to districts in which venue is purportedly proper. Defendants request that actions be remanded to: (1) the District of Wyoming with respect to the Chadwick action (which was originally *1390brought in the District of New Jersey); (2) the Eastern District of Virginia with respect to the Carter action (which was brought in the Southern District of New York); and (3) the Northern District of Texas with respect to the Richards action (which was brought in the Southern District of Texas). Plaintiffs did not respond to the motion.
The Panel placed these actions on a conditional remand order after receiving the transferee judge's suggestion of remand. Each action now before us was conditionally remanded to the district in which it was filed or removed to from state court. Defendants now suggest that we redirect the remands to three non-originating courts.
After considering all argument of counsel, the Panel finds that Section 1407(a) requires us to remand these three actions to their respective transferor courts. Defendants' request is a matter of first impression. Defendants argue that the parties can waive the right to return to their originating court, akin to what parties often do in the transferee court by waiving their Lexecon objections.1 We are not persuaded by this argument. The parties' waiver of objections to Section 1407 remand does not imbue the Panel with the power to send their cases wherever the parties agree. While parties often waive Lexecon rights for a given case to remain in the transferee court for trial, once the Section 1407 remand process is initiated, the statute unambiguously requires the Panel to return a transferred action to the district from whence it came. Under Section 1407(a), "[e]ach action so transferred shall be remanded by the panel at or before the conclusion of such pretrial proceedings to the district from which it was transferred unless it shall have been previously terminated[.]"
IT IS THEREFORE ORDERED that, pursuant to
SCHEDULE A
MDL No. 2391-IN RE: BIOMET M2A MAGNUM HIP IMPLANT PRODUCTS LIABILITY LITIGATION
Northern District of Indiana
CHADWICK v. BIOMET ORTHOPEDICS, INC., ET AL., C.A. No. 3:12-00614 (D. New Jersey, C.A. No. 2:12-03136)
CARTER v. BIOMET, INC., ET AL., C.A. No. 3:13-00256 (S.D. New York, C.A. No. 1:13-01532)
*1391RICHARDS v. BIOMET ORTHOPEDICS LLC, ET AL., C.A. No. 3:14-00612 (S.D. Texas, C.A. No. 4:14-00232)
Free access — add to your briefcase to read the full text and ask questions with AI
Related
Cite This Page — Counsel Stack
357 F. Supp. 3d 1389, Counsel Stack Legal Research, https://law.counselstack.com/opinion/in-re-biomet-m2a-magnum-hip-implant-prods-liab-litig-jpml-2018.